Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
3D genome mapping in rare immune cells reveals new Crohn’s disease genes
New research brings personalised treatment for Parkinson’s disease closer
Greywolf Therapeutics and Genomics look to develop first‑in‑class autoimmune diseases treatments
Priority review for potential first approved treatment for warm autoimmune haemolytic anaemia
New first-in-class therapy for chronic graft-versus-host disease approved in Australia
Scientists discover new way to make drug-resistant cancer treatable
KAIST identifies viruses and variants simultaneously by controlling CRISPR speed
Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma